Home › Research › Biomarkers
The application of proteomics and genomics to the study of age-related neurodegeneration and neuroprotection
Weinreb O, Drigues N, Sagi Y, Reznick AZ, Amit T, Youdim MB.. Antioxidants & redox signaling, 2007-02-01
Topic: Brain proteins, microglia and lab models
Plain-language summary
The present study aimed to acquire more information on aging-related alterations, using proteomic and genomic analyses of hippocampus from young (8 months) and old (27 months) rats. In the old rats, the proteomic analysis identified changes in proteins related to the iron-mediated oxidative stress (OS) pathway, including reduction in antioxidant enzymes (e.g., peroxiredoxin, cytochrome c oxidase) and induction of ferritin. Furthermore, the neurofilament light peptide, associated with neurodegenerative processes, was enhanced and binding/ chaperone proteins were altered in old vs. young rats. At the genes levels, significant molecular changes related to neurodegeneration were identified in aged rat hippocampus. Thus, the effects of the potent neuroprotective compounds, the anti-Parkinson drug, rasagiline and the anti-Alzheimer drug, ladostigil (1 mg/kg, for 30 days) on gene expression in the hippocampus were further investigated. Both drugs reversed the effect of aging on the expression of various mitochondrial and key regulator genes involved in neurodegeneration, cell survival, synaptogenesis, oxidation, and metabolism. These results support the hypothesis that OS and mitochondrial dysfunction may play a pivotal role in aging and age-associated neurodegenerative diseases, and can serve as potential clinical targets for future therapy.
What this study adds
Evidence grade: Low
In old versus young rats, hippocampal proteins related to iron-mediated oxidative stress and neurofilament light changed, and the drugs rasagiline and ladostigil reversed aging effects on several genes. This is animal and gene-expression work suggesting oxidative stress and mitochondrial dysfunction as possible targets, not evidence that these drugs treat, cure or prevent Alzheimer's disease in people.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Weinreb, O., Drigues, N., Sagi, Y., Reznick, A. Z., Amit, T., & Youdim, M. B. (2007). The application of proteomics and genomics to the study of age-related neurodegeneration and neuroprotection. Antioxidants & redox signaling. https://doi.org/10.1089/ars.2007.9.169
Vancouver
Weinreb O, Drigues N, Sagi Y, Reznick AZ, Amit T, Youdim MB. The application of proteomics and genomics to the study of age-related neurodegeneration and neuroprotection. Antioxidants & redox signaling. 2007. doi:10.1089/ars.2007.9.169. PMID: 17115941.
BibTeX
@article{weinreb2007-17115941,
author = {Weinreb, O. and Drigues, N. and Sagi, Y. and Reznick, A. Z. and Amit, T. and Youdim, M. B.},
title = {{The application of proteomics and genomics to the study of age-related neurodegeneration and neuroprotection}},
journal = {Antioxidants \& redox signaling},
year = {2007},
doi = {10.1089/ars.2007.9.169},
pmid = {17115941},
url = {https://doi.org/10.1089/ars.2007.9.169}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Furthermore, the neurofilament light peptide, associated with neurodegenerative processes, was enhanced and binding/ chaperone proteins were altered in old vs. young rats.
- At the genes levels, significant molecular changes related to neurodegeneration were identified in aged rat hippocampus.
- These results support the hypothesis that OS and mitochondrial dysfunction may play a pivotal role in aging and age-associated neurodegenerative diseases, and can serve as potential clinical targets for future therapy.
Why it matters
In old versus young rats, hippocampal proteins related to iron-mediated oxidative stress and neurofilament light changed, and the drugs rasagiline and ladostigil reversed aging effects on several genes. This is animal and gene-expression work suggesting oxidative stress and mitochondrial dysfunction as possible targets, not evidence that these drugs treat, cure or prevent Alzheimer's disease in people.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Evidence strengthLow
How this study scored 37/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Antioxidants & redox signaling) |
| Journal's citation record | 3 / 4 | Antioxidants and Redox Signaling: journal h-index 274 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2007 — within 20 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 4 / 7 | Cited 47 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 2.2 citations a year over 21 year(s) since 2007 |
| Impact for its field and year | 2 / 6 | Cited 1.7× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author Moussa B. H. Youdim: h-index 113 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Technion – Israel Institute of Technology: institution h-index 764 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 17115941) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 37 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription Unpaywall, Europe PMC and OpenAlex found no free copy of the full text (checked 10 Oct 2026), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Biomarkers from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.